These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 663464)

  • 1. [Pharmacologic interactions in dopaminergic receptors in the central nervous system (author's transl)].
    Munõz C
    Rev Med Chil; 1978 Mar; 106(3):221-5. PubMed ID: 663464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dopa and dopamine agonists in depression (author's transl)].
    Zarifian E
    Encephale; 1979; 5(5 Suppl):665-70. PubMed ID: 232875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of chlorpromazine on dopaminergic receptor functions in rat brain--difference of the response of several dopaminergic systems after chronic administration (author's transl)].
    Kaneno S
    Seishin Shinkeigaku Zasshi; 1980 Jun; 82(6):335-52. PubMed ID: 7465695
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M; Luchsinger A
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiparkinsonian drugs (author's transl)].
    Ando K
    No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of dopamine receptors in neurological drug treatment.
    Rinne UK
    Ann Clin Res; 1988; 20(5):334-9. PubMed ID: 3218905
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors.
    Olanow CW; Obeso JA
    Neurology; 2000; 55(11 Suppl 4):S72-7; discussion S78-81. PubMed ID: 11147513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonstriatal dopaminergic neurons: Section VI. Action of dopamine at synaptic level:influence on postsynaptic cells: Introduction: action of dopamine at synaptic level: influence on postsynaptic cells.
    Iversen LL
    Adv Biochem Psychopharmacol; 1977; 16():381-3. PubMed ID: 883549
    [No Abstract]   [Full Text] [Related]  

  • 9. The short-duration response to apomorphine: implications for the mechanism of dopaminergic effects in parkinsonism.
    Gancher ST; Woodward WR; Gliessman P; Boucher B; Nutt JG
    Ann Neurol; 1990 Jun; 27(6):660-5. PubMed ID: 2360803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain dopamine receptors: structure, functional role, and modulation by psychotropic substances].
    Raevskiĭ KS
    Vopr Med Khim; 1997; 43(6):553-65. PubMed ID: 9503573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CB 154 in the treatment of parkinson's disease--results of the association with L-DOPA + DDI (author's transl)].
    Meco G; Casacchia M; Zamponi A; Agnoli A
    Schweiz Rundsch Med Prax; 1976 May; 65(18):557-9. PubMed ID: 989900
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug modification of the dopaminergic system in chorea].
    Rektor I
    Cesk Neurol Neurochir; 1978 Jan; 41(1):54-60. PubMed ID: 624125
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.
    Grace AA
    Mov Disord; 2008; 23 Suppl 3():S560-9. PubMed ID: 18781673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interrelationship of the tranquilizers diazepam and lonetil with dopamine mediation in the central nervous system].
    Ovcharov R; Danchev N
    Eksp Med Morfol; 1981; 20(2):88-96. PubMed ID: 7250025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relevance of dopaminergic system to the catalepsy induced by tetrahydroberberine (author's transl)].
    Wang XL; Hong GX; Jin GZ
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):230-4. PubMed ID: 6462020
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of hypothalamic dopamine in blood pressure regulation].
    Elghozi JL
    Ann Med Interne (Paris); 1983; 134(3):246-8. PubMed ID: 6625421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Central depletion of transmitters by reserpine and motor behavior in the rat (author's transl)].
    Funk KF; Schmidt J; Westermann KH
    Acta Biol Med Ger; 1980; 39(8-9):923-7. PubMed ID: 7282222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease. The L-dopa era.
    Yahr MD
    Adv Neurol; 1993; 60():11-7. PubMed ID: 8420128
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dopaminergic mechanisms of brain aging (a review of the literature)].
    Man'kovskiĭ NB; Kuznetsova SM; Ianovich LA; Red'ko LA
    Vrach Delo; 1989 Sep; (9):83-8. PubMed ID: 2692298
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.
    Scatton B
    Adv Biochem Psychopharmacol; 1980; 24():31-6. PubMed ID: 6105783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.